203 related articles for article (PubMed ID: 27129914)
1. Treatment Considerations and the Role of the Clinical Pharmacist Throughout Transitions of Care for Patients With Acute Heart Failure.
McNeely EB
J Pharm Pract; 2017 Aug; 30(4):441-450. PubMed ID: 27129914
[TBL] [Abstract][Full Text] [Related]
2. A Review of the Role of the Pharmacist in Heart Failure Transition of Care.
Anderson SL; Marrs JC
Adv Ther; 2018 Mar; 35(3):311-323. PubMed ID: 29488151
[TBL] [Abstract][Full Text] [Related]
3. Upcoming Challenges in Multidisciplinary Heart Failure Management: Active Role of Future Clinical Pharmacists.
Motiejunaite J; Chouihed T; Mebazaa A
Clin Pharmacol Ther; 2017 Aug; 102(2):180-182. PubMed ID: 28581206
[TBL] [Abstract][Full Text] [Related]
4. Care transitions in elderly heart failure patients: current practices and the pharmacist's role.
Kitts NK; Reeve AR; Tsu L
Consult Pharm; 2014 Mar; 29(3):179-90. PubMed ID: 24589767
[TBL] [Abstract][Full Text] [Related]
5. Implementation and Effect of a Pharmacist-to-Pharmacist Transitions of Care Initiative on Ambulatory Care Sensitive Conditions.
McFarland MS; Thomas AM; Young E; Bryant C; Hughes JC; Hoffman J; Baker JW
J Manag Care Spec Pharm; 2020 Apr; 26(4):513-519. PubMed ID: 32223605
[TBL] [Abstract][Full Text] [Related]
6. Clinical pharmacy services in heart failure: an opinion paper from the Heart Failure Society of America and American College of Clinical Pharmacy Cardiology Practice and Research Network.
Milfred-Laforest SK; Chow SL; Didomenico RJ; Dracup K; Ensor CR; Gattis-Stough W; Heywood JT; Lindenfeld J; Page RL; Patterson JH; Vardeny O; Massie BM
J Card Fail; 2013 May; 19(5):354-69. PubMed ID: 23663818
[TBL] [Abstract][Full Text] [Related]
7. The Effect of Clinical Pharmacists on Readmission Rates of Heart Failure Patients in the Accountable Care Environment.
Schumacher C; Moaddab G; Colbert M; Kliethermes MA
J Manag Care Spec Pharm; 2018 Aug; 24(8):795-799. PubMed ID: 30058987
[TBL] [Abstract][Full Text] [Related]
8. Interprofessional care collaboration for patients with heart failure.
Boykin A; Wright D; Stevens L; Gardner L
Am J Health Syst Pharm; 2018 Jan; 75(1):e45-e49. PubMed ID: 29273612
[TBL] [Abstract][Full Text] [Related]
9. Postdischarge community pharmacist-provided home services for patients after hospitalization for heart failure.
Kalista T; Lemay V; Cohen L
J Am Pharm Assoc (2003); 2015; 55(4):438-42. PubMed ID: 26161487
[TBL] [Abstract][Full Text] [Related]
10. Implementation of an emergency department-based clinical pharmacist transitions-of-care program.
Hohner E; Ortmann M; Murtaza U; Chopra S; Ross PA; Swarthout M; Efird L; Pherson E; Saheed M
Am J Health Syst Pharm; 2016 Aug; 73(15):1180-7. PubMed ID: 27440625
[TBL] [Abstract][Full Text] [Related]
11. Improving transitions of care for critically ill adult patients on pulmonary arterial hypertension medications.
Martirosov AL; Smith ZR; Hencken L; MacDonald NC; Griebe K; Fantuz P; Grafton G; Hegab S; Ismail R; Jackson B; Kelly B; Miller M; Awdish R
Am J Health Syst Pharm; 2020 Jun; 77(12):958-965. PubMed ID: 32495842
[TBL] [Abstract][Full Text] [Related]
12. Chronic Obstructive Pulmonary Disease and Heart Failure Self-Management Kits for Outpatient Transitions of Care.
Boylan P; Joseph T; Hale G; Moreau C; Seamon M; Jones R
Consult Pharm; 2018 Mar; 33(3):152-158. PubMed ID: 29720300
[TBL] [Abstract][Full Text] [Related]
13. [Role of the Pharmacist within the Heart Failure Team].
Terasaki N
Yakugaku Zasshi; 2016; 136(8):1125-8. PubMed ID: 27477729
[TBL] [Abstract][Full Text] [Related]
14. Pharmacist-led transitions-of-care program reduces 30-day readmission rates for Medicare patients in a large health system.
Miller D; Ramsey M; L'Hommedieu TR; Verbosky L
Am J Health Syst Pharm; 2020 Jun; 77(12):972-978. PubMed ID: 32313954
[TBL] [Abstract][Full Text] [Related]
15. Pharmacist linkage in care transitions: From academic medical center to community.
Bloodworth LS; Malinowski SS; Lirette ST; Ross LA
J Am Pharm Assoc (2003); 2019; 59(6):896-904. PubMed ID: 31590926
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of the Pharmacist-Involved Multidisciplinary Management of Heart Failure to Improve Hospitalizations and Mortality Rates in 4630 Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Parajuli DR; Kourbelis C; Franzon J; Newman P; Mckinnon RA; Shakib S; Whitehead D; Clark RA
J Card Fail; 2019 Sep; 25(9):744-756. PubMed ID: 31351119
[TBL] [Abstract][Full Text] [Related]
17. Drug therapy problems and medication discrepancies during care transitions in super-utilizers.
Surbhi S; Munshi KD; Bell PC; Bailey JE
J Am Pharm Assoc (2003); 2016; 56(6):633-642.e1. PubMed ID: 27720595
[TBL] [Abstract][Full Text] [Related]
18. Rationale and design of the Pharmacist Intervention for Low Literacy in Cardiovascular Disease (PILL-CVD) study.
Schnipper JL; Roumie CL; Cawthon C; Businger A; Dalal AK; Mugalla I; Eden S; Jacobson TA; Rask KJ; Vaccarino V; Gandhi TK; Bates DW; Johnson DC; Labonville S; Gregory D; Kripalani S;
Circ Cardiovasc Qual Outcomes; 2010 Mar; 3(2):212-9. PubMed ID: 20233982
[TBL] [Abstract][Full Text] [Related]
19. The pharmacist role in predicting and improving medication adherence in heart failure patients.
Davis EM; Packard KA; Jackevicius CA
J Manag Care Spec Pharm; 2014 Jul; 20(7):741-55. PubMed ID: 24967527
[TBL] [Abstract][Full Text] [Related]
20. [Role of Community Pharmacists in Home Healthcare].
Saiga M
Yakugaku Zasshi; 2018; 138(6):791-795. PubMed ID: 29863049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
